Cite
HARVARD Citation
Stagno, F. et al. (2016). Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Expert review of anticancer therapy. 16 (3), pp. 273-278. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stagno, F. et al. (2016). Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes. Expert review of anticancer therapy. 16 (3), pp. 273-278. [Online].